Which has preferable valuation & earnings, ELV or CNC?

Elevance Health has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Elevance Health $199.13B 0.43 $5.66B $23.51 16.80 Centene $194.78B 0.17 -$6.67B -$13.14 N/A

Does the media prefer ELV or CNC?

In the previous week, Elevance Health had 18 more articles in the media than Centene. MarketBeat recorded 27 mentions for Elevance Health and 9 mentions for Centene. Elevance Health's average media sentiment score of 1.33 beat Centene's score of 0.69 indicating that Elevance Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elevance Health 12 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Centene 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to MOH or CNC?

In the previous week, Molina Healthcare and Molina Healthcare both had 9 articles in the media. Molina Healthcare's average media sentiment score of 1.38 beat Centene's score of 0.69 indicating that Molina Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Molina Healthcare 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Centene 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor CNC or SEM?

In the previous week, Centene had 6 more articles in the media than Select Medical. MarketBeat recorded 9 mentions for Centene and 3 mentions for Select Medical. Centene's average media sentiment score of 0.69 beat Select Medical's score of 0.48 indicating that Centene is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Centene 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Select Medical 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better earnings and valuation, CI or CNC?

Cigna Group has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Cigna Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cigna Group $276.88B 0.27 $5.96B $23.59 11.99 Centene $194.78B 0.17 -$6.67B -$13.14 N/A

Is CI or CNC more profitable?

Cigna Group has a net margin of 2.26% compared to Centene's net margin of -3.25%. Cigna Group's return on equity of 19.75% beat Centene's return on equity. Company Net Margins Return on Equity Return on Assets Cigna Group 2.26% 19.75% 5.30% Centene -3.25% 5.57% 1.54%

Does the media prefer CI or CNC?

In the previous week, Cigna Group had 4 more articles in the media than Centene. MarketBeat recorded 13 mentions for Cigna Group and 9 mentions for Centene. Cigna Group's average media sentiment score of 1.02 beat Centene's score of 0.69 indicating that Cigna Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cigna Group 7 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Centene 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, HUM or CNC?

Humana has higher earnings, but lower revenue than Centene. Centene is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Humana $129.66B 0.36 $1.19B $9.35 41.09 Centene $194.78B 0.17 -$6.67B -$13.14 N/A

Is HUM or CNC more profitable?

Humana has a net margin of 0.82% compared to Centene's net margin of -3.25%. Humana's return on equity of 10.45% beat Centene's return on equity. Company Net Margins Return on Equity Return on Assets Humana 0.82% 10.45% 3.75% Centene -3.25% 5.57% 1.54%

Does the media prefer HUM or CNC?

In the previous week, Humana had 7 more articles in the media than Centene. MarketBeat recorded 16 mentions for Humana and 9 mentions for Centene. Centene's average media sentiment score of 0.69 beat Humana's score of 0.48 indicating that Centene is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Humana 7 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Centene 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Centene (CNC) Competitors

$65.69 -0.04 (-0.06%)

Closing price 06/26/2026 03:59 PM Eastern

Extended Trading

$65.86 +0.17 (+0.26%)

As of 05:36 AM Eastern

Compare

CNC vs. ELV, MOH, SEM, CI, and HUM

Should you buy Centene stock or one of its competitors? MarketBeat compares Centene with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Centene include Elevance Health (ELV), Molina Healthcare (MOH), Select Medical (SEM), Cigna Group (CI), and Humana (HUM). These companies are all part of the "medical" sector.

How does Centene compare to Elevance Health?

Elevance Health (NYSE:ELV) and Centene (NYSE:CNC) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, risk, profitability, dividends, earnings and media sentiment.

Elevance Health has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elevance Health	$199.13B	0.43	$5.66B	$23.51	16.80
Centene	$194.78B	0.17	-$6.67B	-$13.14	N/A

In the previous week, Elevance Health had 18 more articles in the media than Centene. MarketBeat recorded 27 mentions for Elevance Health and 9 mentions for Centene. Elevance Health's average media sentiment score of 1.33 beat Centene's score of 0.69 indicating that Elevance Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elevance Health	12 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Centene	3 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Elevance Health has a net margin of 2.62% compared to Centene's net margin of -3.25%. Elevance Health's return on equity of 15.58% beat Centene's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elevance Health	2.62%	15.58%	5.57%
Centene	-3.25%	5.57%	1.54%

Elevance Health currently has a consensus price target of $416.11, suggesting a potential upside of 5.38%. Centene has a consensus price target of $60.78, suggesting a potential downside of 7.48%. Given Elevance Health's stronger consensus rating and higher probable upside, research analysts clearly believe Elevance Health is more favorable than Centene.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elevance Health	0 Sell rating(s)	9 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.61
Centene	2 Sell rating(s)	10 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.35

89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 93.6% of Centene shares are owned by institutional investors. 0.3% of Elevance Health shares are owned by insiders. Comparatively, 0.4% of Centene shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Elevance Health has a beta of 0.67, indicating that its stock price is 33% less volatile than the broader market. Comparatively, Centene has a beta of 1.09, indicating that its stock price is 9% more volatile than the broader market.

Summary

Elevance Health beats Centene on 13 of the 17 factors compared between the two stocks.

How does Centene compare to Molina Healthcare?

Molina Healthcare (NYSE:MOH) and Centene (NYSE:CNC) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, media sentiment, risk, valuation and earnings.

Molina Healthcare currently has a consensus price target of $184.81, suggesting a potential downside of 19.58%. Centene has a consensus price target of $60.78, suggesting a potential downside of 7.48%. Given Centene's stronger consensus rating and higher probable upside, analysts clearly believe Centene is more favorable than Molina Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Molina Healthcare	1 Sell rating(s)	13 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.12
Centene	2 Sell rating(s)	10 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.35

In the previous week, Molina Healthcare and Molina Healthcare both had 9 articles in the media. Molina Healthcare's average media sentiment score of 1.38 beat Centene's score of 0.69 indicating that Molina Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Molina Healthcare	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Centene	3 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Molina Healthcare has higher earnings, but lower revenue than Centene. Centene is trading at a lower price-to-earnings ratio than Molina Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Molina Healthcare	$45.43B	0.26	$472M	$3.38	67.99
Centene	$194.78B	0.17	-$6.67B	-$13.14	N/A

Molina Healthcare has a net margin of 0.42% compared to Centene's net margin of -3.25%. Molina Healthcare's return on equity of 8.76% beat Centene's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Molina Healthcare	0.42%	8.76%	2.32%
Centene	-3.25%	5.57%	1.54%

98.5% of Molina Healthcare shares are owned by institutional investors. Comparatively, 93.6% of Centene shares are owned by institutional investors. 1.4% of Molina Healthcare shares are owned by company insiders. Comparatively, 0.4% of Centene shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Molina Healthcare has a beta of 0.8, suggesting that its stock price is 20% less volatile than the broader market. Comparatively, Centene has a beta of 1.09, suggesting that its stock price is 9% more volatile than the broader market.

Summary

Molina Healthcare beats Centene on 10 of the 16 factors compared between the two stocks.

How does Centene compare to Select Medical?

Centene (NYSE:CNC) and Select Medical (NYSE:SEM) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and earnings.

93.6% of Centene shares are held by institutional investors. Comparatively, 89.5% of Select Medical shares are held by institutional investors. 0.4% of Centene shares are held by company insiders. Comparatively, 16.0% of Select Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Centene currently has a consensus target price of $60.78, indicating a potential downside of 7.48%. Select Medical has a consensus target price of $15.50, indicating a potential downside of 6.29%. Given Select Medical's higher probable upside, analysts plainly believe Select Medical is more favorable than Centene.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Centene	2 Sell rating(s)	10 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.35
Select Medical	0 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.14

Centene has a beta of 1.09, indicating that its share price is 9% more volatile than the broader market. Comparatively, Select Medical has a beta of 1.01, indicating that its share price is 1% more volatile than the broader market.

In the previous week, Centene had 6 more articles in the media than Select Medical. MarketBeat recorded 9 mentions for Centene and 3 mentions for Select Medical. Centene's average media sentiment score of 0.69 beat Select Medical's score of 0.48 indicating that Centene is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Centene	3 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Select Medical	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Select Medical has lower revenue, but higher earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Select Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Centene	$194.78B	0.17	-$6.67B	-$13.14	N/A
Select Medical	$5.45B	0.38	$146.22M	$1.06	15.60

Select Medical has a net margin of 2.42% compared to Centene's net margin of -3.25%. Select Medical's return on equity of 6.62% beat Centene's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Centene	-3.25%	5.57%	1.54%
Select Medical	2.42%	6.62%	2.30%

Summary

Select Medical beats Centene on 9 of the 17 factors compared between the two stocks.

How does Centene compare to Cigna Group?

Cigna Group (NYSE:CI) and Centene (NYSE:CNC) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, risk, profitability, institutional ownership and earnings.

In the previous week, Cigna Group had 4 more articles in the media than Centene. MarketBeat recorded 13 mentions for Cigna Group and 9 mentions for Centene. Cigna Group's average media sentiment score of 1.02 beat Centene's score of 0.69 indicating that Cigna Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cigna Group	7 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Centene	3 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Cigna Group has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Cigna Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cigna Group	$276.88B	0.27	$5.96B	$23.59	11.99
Centene	$194.78B	0.17	-$6.67B	-$13.14	N/A

Cigna Group has a beta of 0.28, meaning that its share price is 72% less volatile than the broader market. Comparatively, Centene has a beta of 1.09, meaning that its share price is 9% more volatile than the broader market.

Cigna Group has a net margin of 2.26% compared to Centene's net margin of -3.25%. Cigna Group's return on equity of 19.75% beat Centene's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cigna Group	2.26%	19.75%	5.30%
Centene	-3.25%	5.57%	1.54%

Cigna Group currently has a consensus price target of $338.30, indicating a potential upside of 19.61%. Centene has a consensus price target of $60.78, indicating a potential downside of 7.48%. Given Cigna Group's stronger consensus rating and higher possible upside, research analysts plainly believe Cigna Group is more favorable than Centene.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cigna Group	0 Sell rating(s)	6 Hold rating(s)	15 Buy rating(s)	1 Strong Buy rating(s)	2.77
Centene	2 Sell rating(s)	10 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.35

87.0% of Cigna Group shares are owned by institutional investors. Comparatively, 93.6% of Centene shares are owned by institutional investors. 0.6% of Cigna Group shares are owned by insiders. Comparatively, 0.4% of Centene shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Cigna Group beats Centene on 14 of the 16 factors compared between the two stocks.

How does Centene compare to Humana?

Humana (NYSE:HUM) and Centene (NYSE:CNC) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings.

Humana has a beta of 0.76, meaning that its stock price is 24% less volatile than the broader market. Comparatively, Centene has a beta of 1.09, meaning that its stock price is 9% more volatile than the broader market.

Humana has higher earnings, but lower revenue than Centene. Centene is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Humana	$129.66B	0.36	$1.19B	$9.35	41.09
Centene	$194.78B	0.17	-$6.67B	-$13.14	N/A

In the previous week, Humana had 7 more articles in the media than Centene. MarketBeat recorded 16 mentions for Humana and 9 mentions for Centene. Centene's average media sentiment score of 0.69 beat Humana's score of 0.48 indicating that Centene is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Humana	7 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Centene	3 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Humana presently has a consensus target price of $293.09, indicating a potential downside of 23.71%. Centene has a consensus target price of $60.78, indicating a potential downside of 7.48%. Given Centene's stronger consensus rating and higher possible upside, analysts clearly believe Centene is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Humana	3 Sell rating(s)	16 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.25
Centene	2 Sell rating(s)	10 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.35

Humana has a net margin of 0.82% compared to Centene's net margin of -3.25%. Humana's return on equity of 10.45% beat Centene's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Humana	0.82%	10.45%	3.75%
Centene	-3.25%	5.57%	1.54%

92.4% of Humana shares are owned by institutional investors. Comparatively, 93.6% of Centene shares are owned by institutional investors. 0.2% of Humana shares are owned by company insiders. Comparatively, 0.4% of Centene shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Humana beats Centene on 9 of the 16 factors compared between the two stocks.

Get Centene News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CNC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CNC vs. The Competition

Export

Metric	Centene	MED Industry	Medical Sector	NYSE Exchange
Market Cap	$32.44B	$55.57B	$6.83B	$23.30B
Dividend Yield	N/A	1.71%	2.66%	4.08%
P/E Ratio	-5.00	25.75	25.89	31.64
Price / Sales	0.17	0.64	547.76	20.94
Price / Cash	14.03	23.95	29.09	18.60
Price / Book	1.61	2.83	10.75	4.75
Net Income	-$6.67B	$1.46B	$3.58B	$1.07B
7 Day Performance	3.17%	-1.42%	1.97%	1.36%
1 Month Performance	10.00%	1.99%	-0.24%	0.70%
1 Year Performance	21.69%	-3.00%	34.39%	25.30%

Centene Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CNC Centene	2.9796 of 5 stars	$65.69 -0.1%	$60.78 -7.5%	+21.7%	$32.44B	$194.78B	N/A	61,100
ELV Elevance Health	4.8155 of 5 stars	$401.19 -0.7%	$416.11 +3.7%	+3.6%	$87.12B	$199.13B	17.06	97,100	Trending News Analyst Revision Gap Down
MOH Molina Healthcare	2.3009 of 5 stars	$201.07 +0.4%	$182.73 -9.1%	-22.5%	$10.48B	$45.08B	59.49	19,000	Positive News Upcoming Earnings
SEM Select Medical	4.0013 of 5 stars	$16.65 -0.1%	$15.50 -6.9%	+8.4%	$2.06B	$5.52B	15.70	45,300
CI Cigna Group	4.8644 of 5 stars	$293.92 -1.4%	$338.80 +15.3%	-13.4%	$77.75B	$274.90B	12.46	67,700	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:CNC) was last updated on 6/29/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Centene (CNC) Competitors

CNC vs. ELV, MOH, SEM, CI, and HUM

How does Centene compare to Elevance Health?

Summary

How does Centene compare to Molina Healthcare?

Summary

How does Centene compare to Select Medical?

Summary

How does Centene compare to Cigna Group?

Summary

How does Centene compare to Humana?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNC vs. The Competition

Centene Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Centene (CNC) Competitors

CNC vs. ELV, MOH, SEM, CI, and HUM

How does Centene compare to Elevance Health?

Which has preferable valuation & earnings, ELV or CNC?

Does the media prefer ELV or CNC?

Is ELV or CNC more profitable?

Do analysts prefer ELV or CNC?

Do institutionals and insiders hold more shares of ELV or CNC?

Which has more volatility and risk, ELV or CNC?

Summary

How does Centene compare to Molina Healthcare?

Do analysts prefer MOH or CNC?

Does the media refer more to MOH or CNC?

Which has higher valuation & earnings, MOH or CNC?

Is MOH or CNC more profitable?

Do institutionals & insiders have more ownership in MOH or CNC?

Which has more volatility & risk, MOH or CNC?

Summary

How does Centene compare to Select Medical?

Do institutionals and insiders believe in CNC or SEM?

Do analysts rate CNC or SEM?

Which has more volatility and risk, CNC or SEM?

Does the media favor CNC or SEM?

Which has higher earnings and valuation, CNC or SEM?

Is CNC or SEM more profitable?

Summary

How does Centene compare to Cigna Group?

Does the media prefer CI or CNC?

Which has better earnings and valuation, CI or CNC?

Which has more volatility & risk, CI or CNC?

Is CI or CNC more profitable?

Do analysts rate CI or CNC?

Do institutionals & insiders hold more shares of CI or CNC?

Summary

How does Centene compare to Humana?

Which has more risk and volatility, HUM or CNC?

Which has higher valuation and earnings, HUM or CNC?

Does the media prefer HUM or CNC?

Do analysts rate HUM or CNC?

Is HUM or CNC more profitable?

Do insiders & institutionals hold more shares of HUM or CNC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CNC vs. The Competition

Centene Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools